WASHINGTON—Militarizing the body’s natural immune responses so that it can fight off cancerous uprisings has been seen as a promising strategy for years. Now, a sneak peek of data from a small clinical trial suggests that the method may in fact be as useful as doctors hope—but there are still some serious kinks to work out.
Full article